Opinion statement Human T-lymphotrophic virus 1 (HTLV-1)-associated myelopathy/tropical
spastic paraparesis (HAM/TSP) is a disabling myelopathy, but clinical trials of specific drugs …

ABSTRACT Introduction Nearly 2–3% of those 10 to 20 million individuals infected with the
Human T-cell lymphotropic virus type-1 (HTLV-1); are predisposed to developing HTLV-1 …

Background The progression of neurological disability in human T-lymphotropic virus 1
(HTLV-1)–associated myelopathy/tropical spastic paraparesis (HAM/TSP) remains …

HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a
neurodegenerative disease of the central nervous system induced by human T-lymphotropic …

Human T-cell leukemia virus type 1 (HTLV-1) is the ethiologic agent of the neurological
disorder HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Although …

Human T-lymphotropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis
(HAM/TSP) is a progressive disease of the CNS that causes weakness or paralysis of the …

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is a
neuropathological disorder in 1–3% of individuals infected with Human T-lymphotropic virus …

Abstract Objective HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
can progress slowly or rapidly even though a set of symptoms such as spastic paraparesis …

The human T cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that infects 10–20 million
persons around the world. Initially associated with the hematological malignancy adult T cell …

Human T cell lymphotropic virus 1 (HTLV-1) is a human retrovirus and infects approximately
10–20 million people worldwide. While the majority of infected people are asymptomatic …